Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

Just four months after Eli Lilly and British biotech Alchemab penned a discovery collaboration, the Big Pharma is licensing ...

U.S. stock index futures fell on Tuesday after President Donald Trump's plans for potential pharma tariffs renewed fears ...

Financial terms of the new agreement include an upfront payment to secure rights to Alchemab's lead ALS candidate, ATLX-1282, ...

Lilly plans to break ground Tuesday afternoon on its $4.5 billion Lilly Medicine Foundry in Lebanon. Lilly Chair and CEO Dave ...

LLY is bullish in weekly sequence from all time low. It favors rally in (V) after double correction ended at $677.09 low in ...

U.S. stock index futures were lower on Tuesday after President Donald Trump's comments on potential pharma tariffs renewed ...

Branded drug manufacturers, including Eli Lilly and Company (Eli Lilly), have been pursuing various legal actions against compounding pharmacies ...

The order directs the U.S. Food and Drug Administration to reduce the time it takes to approve drug manufacturing plants in ...

(Reuters) -Bristol Myers Squibb will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in ...

Fawn Weaver, co-founder of Uncle Nearest Whiskey, encouraged FAMU graduates to defy limitations in her commencement speech.

A recent study from Ixlayer indicates patients are looking for pharma companies to do more to improve upon their current DTC offerings.